Publication details

Aktuální onkologická léčba high-grade gliomů

Title in English Current strategy for treatment of high-grade gliomas
Authors

POSPÍŠIL Petr KAZDA Tomáš ŠLAMPA Pavel JANČÁLEK Radim

Year of publication 2016
Type Article in Periodical
Magazine / Source Neurologie pro praxi
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords high-grade glioma; glioblastoma; radiotherapy; chemotherapy; prognostic factors; molecular biomarkers
Description In recent decades, there have been significant advances in the standard therapy of high-grade gliomas. New surgical procedures were introduced; radiotherapy methods were improved. It was also found that the use of chemotherapy in specific tumor types further improves the treatment effects. Diagnostic procedures developed as well. However, treatment results are still not satisfactory. The survival of patients with glioblastoma improved only by a few months in the last several decades. The mainstay of malignant gliomas treatment is always maximal safe tumor resection as feasible without functional consequences. Additional treatment depends on histology but also prognostic and predictive factors. The main traditional prognostic factors include age, performance status and the extent of resection. Novel prognostic factors are cytogenetic and molecular biomarkers, some of which may also predict response to the treatment.

You are running an old browser version. We recommend updating your browser to its latest version.

More info